Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Chronic Heart Failure: early-phase trial registry

5 of 13 indexed Chronic Heart Failure trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 5 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Chronic Heart Failure: 13 US clinical trials tracked, 5 recruiting.

Chronic Heart Failure is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Nile Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-heart-failure

OPEN 5 | RECR 38% | LATE 1 | EARLY 3 | RANK #1315 | SPON 1

Nearest open-share peer: Anaplastic Oligodendroglioma (38% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Chronic Heart Failure (this)38%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Chronic Heart Failure

Chronic Heart Failure lists 5 open slots (38% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Heart Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Heart Failure is recruiting below its size-band peers.

    5 of 13 indexed trials (38.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Chronic Heart Failure trials is spread across many organizations.

    Nile Therapeutics accounts for 1 of 13 trials (7.7%). 13 distinct sponsors appear on at least one study for this condition label.

  3. Typical Chronic Heart Failure enrolment sits around 150 participants.

    Median target enrolment is 150 among the 13 trials that report a genuine target (sentinel values excluded). 4 of those (30.8%) plan for fewer than 100 participants.

  4. Chronic Heart Failure research is mostly interventional.

    10 interventional and 3 observational studies make up this index (76.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22Phase 31

Open and recent trials

13 total, page 1 of 1

RECRUITING Phase 3 1,900 participants

Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

Pharmacosmos A/S

NCT06929806

RECRUITING NA 1,500 participants

The HEARTFELT Study

Heartfelt Technologies

NCT06222099

RECRUITING NA 150 participants

Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

XSpline S.p.A.

NCT05327062

RECRUITING NA 136 participants

Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

Beth Israel Deaconess Medical Center

NCT05934565

RECRUITING NA 40 participants

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

AquaPass Medical

NCT06360380

ACTIVE NOT RECRUITING Phase 2 314 participants

Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

Akros Pharma

NCT06017609

ACTIVE NOT RECRUITING 300 participants

Destination Therapy Post Approval Study

Medtronic Cardiac Rhythm and Heart Failure

NCT03681210

ACTIVE NOT RECRUITING 216 participants

R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances

Cordio Medical

NCT05876533

COMPLETED NA 247 participants

Cost and Shared Decision-Making for Heart Failure

Emory University

NCT04793880

COMPLETED NA 104 participants

Telehealth Management in HF Disparity Patients

Northwell Health

NCT02196922

COMPLETED 77 participants

Iron Deficiency and FGF23 Regulation in CKD and HF

Northwestern University

NCT03106298

COMPLETED Phase 1 58 participants

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

Nile Therapeutics

NCT01316432

COMPLETED Phase 2 25 participants

A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

NCT00094562

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 3 1

Named interventions

Most-linked intervention names on Chronic Heart Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fish oil supplement Drug
1 trials
Cenderitide Drug
1 trials
Telehealth Self Management (TSM) Device
1 trials
Heart Failure Medicines Checklist Behavioral
1 trials
Medication Cost Information Behavioral
1 trials
Iron Sucrose Drug
1 trials
HeartWare Ventricular Assist Device Device
1 trials
JTT-861 Capsules Drug
1 trials

US sites by state

Facility locations filed on Chronic Heart Failure trials. A trial with sites in several states counts in each.

Illinois 4 trials
Florida 4 trials
New York 3 trials
Massachusetts 3 trials
Georgia 3 trials
California 3 trials
Pennsylvania 2 trials
North Carolina 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Heart Failure page

13 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 5 Chronic Heart Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Nile Therapeutics sponsors the most Chronic Heart Failure trials on record, review their full trial history before evaluating a specific study. See Nile Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Heart Failure condition card totals 13 registered trials; most-linked intervention Fish oil supplement; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.